In their May 2024 Nature Communications paper, Chen et al used data simulated based on Reactome pathways to validate their Functional Representation of Gene Signatures (FRoGS) algorithm, a deep learning-based approach that was designed to improve the accuracy of drug target predictions by addressing limitations of gene identity-based pathway analysis.